Dr. Ahn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Alnylam Pharmaceuticals
Cambridge, MA 02140- Is this information wrong?
Summary
- Andy Ahn is a neurologist and neuroscientist focused on research and development of medicines for neurologic disease. He received his medical degree from Harvard Medical School and scientific training in the Neurobiology program at Harvard. He has clinical specialization in headache and pain medicine, and pharmacologic development experience in multiple indications in neurology and psychiatry
Education & Training
- University of California (San Francisco)Residency, Neurology, 1997 - 2000
- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1996 - 1997
- Harvard Medical SchoolClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - 2025
- FL State Medical License 2010 - 2016
Awards, Honors, & Recognition
- Fellow American Headache Society
Publications & Presentations
PubMed
- 5 citationsDose selection for fremanezumab (AJOVY) phase 3 pediatric migraine studies using pharmacokinetic data from a pediatric phase 1 study and a population pharmacokinetic m...Orit Cohen-Barak, Andrijana Radivojevic, Aksana Jones, Jill Fiedler-Kelly, Michael Gillespie, Michael Brennan, Dikla Gutman, Michele Rasamoelisolo, Hussein Hallak, Pip...> ;Cephalalgia. 2021 May 17
- 166 citationsDiscovery and validation of biomarkers to aid the development of safe and effective pain therapeutics: challenges and opportunities.Karen D. Davis, Nima Aghaeepour, Andrew H. Ahn, Martin S. Angst, David Borsook, Ashley Brenton, Michael E. Burczynski, Christopher Crean, Robert R. Edwards, Brice Gaud...> ;Nature Reviews. Neurology. 2020 Jun 15
- 27 citations5‐HT1D Receptor Immunoreactivity in the Sphenopalatine Ganglion: Implications for the Efficacy of Triptans in the Treatment of Autonomic Signs Associated With Cluster ...Jason J. Ivanusic, Matthew M. Kwok, and Andrew H. Ahn Md, Ernest A. Jennings> ;Headache. 2011 Mar 1
- Join now to see all
External Links
- LinkedInhttp://www.linkedin.com/in/andrew-ahn-md-phd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: